OUD Provider and Clinical Guidance

MCC of VA Provider Guidance
Clinical Guidance and Reference

SAMHSA Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants

Opioid Use and Opioid Use Disorder in Pregnancy. Committee Opinion No. 711. The American College of Obstetricians and Gynecologists (ACOG). August 2017

Society of Maternal Fetal Medicine Special Report – Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine;  2019

Council on Patient Safety in Women’s Health

Obstetric Care for Women with Opioid Use Disorder Patient Safety Bundle developed by the Alliance for Innovation in Maternal Health (AIM) – a cooperative agreement between the American College of Obstetricians and Gynecologists (ACOG) and the Health and Resources Services Administration Maternal-Child Health Bureau (HRSA-MCHB) – endorsed and disseminated by the Council on Patient Safety in Women’s Health.

Virginia Guidelines and Resources

Virginia Neonatal Perinatal Collaborative (VPNC)

Maternal OUD & NAS Breakout Session Slides

Virginia Department of Social Services (DSS)

Substance Exposed Infants Manual

Department of Medical Assistance Services (DMAS)

Addiction & Recovery Treatment Services (ARTS)

Virginia Department of Health

Opioid Addiction in Virginia

Mandatory Reporting of Substance Exposed Newborns (SEN)

63.2-15093 Code of Virginia: Requires health care providers file a report with CPS if they suspect a child is experiencing withdrawal or was born affected by substance abuse due to in utero drug exposure at Report Substance Exposed Newborn

VA Prescription Monitoring Program (PMP)

Register for the Virginia’s Prescription Monitoring Program (PMP) 

If substance use is suspected but not verified by the pregnant woman, you can check the database